Added to YB: 2025-03-18
Pitch date: 2025-03-16
1681.HK [neutral]
Consun Pharmaceutical Group Limited
+97.47%
current return
Author Info
Momentum Financial researches stocks from around the world to invest in for the long-term. Sign up for the newsletter.
Company Info
Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China.
Market Cap
HKD 10.8B
Pitch Price
HKD 7.79
Price Target
N/A
Dividend
5.29%
EV/EBITDA
5.36
P/E
9.34
EV/Sales
2.02
Sector
Pharmaceuticals
Category
growth
News from Consun Pharma (1681)
1681.HK (overview): Consun Pharma advancing CKD drug SK-08 to Phase 1 trials. Strong 2024 performance, exceeding targets. Niaoduqing Granules study for peritoneal dialysis progressing. Jigucao capsules show promise for MAFLD treatment. Low PE of 5.18x vs sector median 7.70x. New plant expansion to double capacity.
Read full article (9 min)